It's too soon to know if the trend will last. But health providers fear the national discourse around vaccines could yield more sickness and death this winter.

A number of diseases tend to peak in the winter, thanks to indoor gatherings that help germs spread. The list includes not ...

U.S. regulators launch new review of infant RSV therapies from Merck, Sanofi, and AstraZeneca amid scrutiny by Health Secretary Robert F. Kennedy Jr.

Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems ...

Learn about the FDA's review of the safety of RSV prevention drugs Clesrovimab and Nirsevimab for infants and toddlers. Find ...

Key Takeaways The U.S. Food and Drug Administration is reviewing two RSV drugs for infantsNo safety issues have been ...

There are four infections that experts expect to start increasing during winter: colds, influenza, COVID-19 and Respiratory Syncytial Virus, or RSV. All four fall under what are called influenza-like ...

DES MOINES, Iowa (KTIV) - The Iowa Department of Health and Human Services (HHS) announces Friday, Nov. 21, the first influenza-related death of the 2025-26 respiratory virus season. The individual ...

“Over the past week, we’ve seen a noticeable rise in emergency visits for cough, congestion, and breathing difficulties in both adults and children, as well as an increase in gastroenteritis cases. We ...

The United States may be facing another difficult influenza season, partly due to lagging vaccination rates and a newly mutated strain called sub-clade-K. This variant has already caused early surges ...

CLEVELAND, Ohio — New Cleveland Clinic research could help improve flu vaccine design by tailoring shots for older and younger adults. A team led by Dr. Ted Ross, Cleveland Clinic’s global director of ...